cycloserine has been researched along with Depressive Disorder, Treatment-Resistant in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, YM; Chen, MH; Cheng, CM; Gueorguieva, R; Hong, CJ; Krystal, JH; Li, CT; Lin, WC; Su, TP; Tsai, SJ; Tu, PC | 1 |
Gangwisch, J; Halberstam, B; Kantrowitz, JT | 1 |
Iosifescu, DV | 1 |
2 trial(s) available for cycloserine and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cycloserine; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Ketamine; Male; Middle Aged; Suicide Prevention; Treatment Outcome | 2019 |
Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
Topics: Adult; Bipolar Disorder; Cycloserine; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Young Adult | 2015 |
1 other study(ies) available for cycloserine and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge.
Topics: Cycloserine; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male | 2015 |